Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Ching Ying Huang, Martin W. Nicholson, Jyun Yuan Wang, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110643-110643
Open Access | Times Cited: 21

Showing 21 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Maria Pérez-Araluce, Tomasz Jüngst, Carmen Sanmartín, et al.
Biomimetics (2024) Vol. 9, Iss. 1, pp. 23-23
Open Access | Times Cited: 12
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Hao Zhang, Phung N. Thai, Rabindra V. Shivnaraine, et al.
Cell (2024)
Closed Access | Times Cited: 11
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Martin W. Nicholson, Chien-Yu Ting, Darien Zhing Herr Chan, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1853-1853
Open Access | Times Cited: 37
Greater genetic diversity is needed in human pluripotent stem cell models
Sulagna Ghosh, Ralda Nehme, Lindy E. Barrett
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Evolution and impact of high content imaging
Gregory P. Way, Heba Sailem, Steven Shave, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 7, pp. 292-305
Open Access | Times Cited: 21
Clinical trials in-a-dish for cardiovascular medicine
Xuekun Wu, Kyle Swanson, Zehra Yıldırım, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 7
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes
Kavita Raniga, Aishah Nasir, Nguyen T.N. Vo, et al.
Cell stem cell (2024) Vol. 31, Iss. 3, pp. 292-311
Open Access | Times Cited: 6
iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine
Kelvin K. Hui, Shinya Yamanaka
BioEssays (2024)
Closed Access | Times Cited: 5
Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications
Hyeon Ryoo, Hannah Kimmel, Evi Rondo, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 12
Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells
Tadahisa Sugiura, Dhienda C. Shahannaz, Brandon E. Ferrell
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5772-5772
Open Access | Times Cited: 4
Submission to Stem Cells Reviews and Reports
Rubén Escribá, Meral Beksaç, Annelise Bennaceur‐Griscelli, et al.
Stem Cell Reviews and Reports (2024)
Open Access | Times Cited: 3
Human pluripotent stem cells as a translational toolkit in psychedelic research in vitro
José Alexandre Salerno, Stevens K. Rehen
iScience (2024) Vol. 27, Iss. 5, pp. 109631-109631
Open Access | Times Cited: 2
Tuning pro-survival effects of human induced pluripotent stem cell-derived exosomes using elastin-like polypeptides
Cheng‐Hung Lee, Daniel Hunt, Julien G. Roth, et al.
Biomaterials (2022) Vol. 291, pp. 121864-121864
Closed Access | Times Cited: 5
Functional genomics in stem cell models: considerations and applications
Kaivalya Shevade, Sailaja Peddada, K. Mäder, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs
Martin W. Nicholson, Ching‐Ying Huang, Jyun-Yuan Wang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 765-765
Open Access | Times Cited: 4
Opportunities and Challenges of Human IPSC Technology in Kidney Disease Research
Jia‐Jung Lee, Chuang‐Yu Lin, Hung‐Chun Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 4
Arrhythmic Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction: Mechanisms, Genetics, and Future Directions
Sina Safabakhsh, Abdullah Al-Shaheen, Elizabeth Swiggum, et al.
CJC Open (2022) Vol. 4, Iss. 11, pp. 959-969
Open Access | Times Cited: 3
Immortalized neuronal lines versus human induced pluripotent stem cell-derived neurons as in vitro toxicology models
Xue-Qi Tang, Aaron B. Bowman
Advances in neurotoxicology (2024), pp. 47-81
Closed Access
The long road to the development of stem cells as a model for central nervous system health and disease
Hyunjin Kim, Aaron B. Bowman
Advances in neurotoxicology (2024), pp. 1-45
Closed Access
Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity
Ping-Hsien Wang, Yi‐Hsien Fang, Yen‐Wen Liu, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2764-2764
Open Access | Times Cited: 2
Page 1

Scroll to top